Welcome to LookChem.com Sign In|Join Free

CAS

  • or
21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

77704-58-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 77704-58-6 Structure
  • Basic information

    1. Product Name: 21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I
    2. Synonyms: 21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I;Demycinosylmycinamicin IV;Mycinamicin VII
    3. CAS NO:77704-58-6
    4. Molecular Formula: C29H47NO7
    5. Molecular Weight: 521.68598
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 77704-58-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I(CAS DataBase Reference)
    10. NIST Chemistry Reference: 21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I(77704-58-6)
    11. EPA Substance Registry System: 21-O-De(6-deoxy-2-O,3-O-dimethyl-β-D-allopyranosyl)-12,13-didehydro-12,12-O-seco-13-deoxymycinamicin I(77704-58-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 77704-58-6(Hazardous Substances Data)

77704-58-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 77704-58-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,7,0 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 77704-58:
(7*7)+(6*7)+(5*7)+(4*0)+(3*4)+(2*5)+(1*8)=156
156 % 10 = 6
So 77704-58-6 is a valid CAS Registry Number.

77704-58-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Mycinamicin VII

1.2 Other means of identification

Product number -
Other names (3E,11E,13E)-(5S,6S,7S,9R,15R,16R)-6-((2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-16-ethyl-15-hydroxymethyl-5,7,9-trimethyl-oxacyclohexadeca-3,11,13-triene-2,10-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:77704-58-6 SDS

77704-58-6Upstream product

77704-58-6Downstream Products

77704-58-6Relevant articles and documents

Biochemical and Structural Characterization of MycCI, a Versatile P450 Biocatalyst from the Mycinamicin Biosynthetic Pathway

Demars, Matthew D.,Sheng, Fang,Park, Sung Ryeol,Lowell, Andrew N.,Podust, Larissa M.,Sherman, David H.

, p. 2642 - 2654 (2016)

Cytochrome P450 monooxygenases (P450s) are some of nature's most ubiquitous and versatile enzymes for performing oxidative metabolic transformations. Their unmatched ability to selectively functionalize inert C-H bonds has led to their increasing employment in academic and industrial settings for the production of fine and commodity chemicals. Many of the most interesting and potentially biocatalytically useful P450s come from microorganisms, where they catalyze key tailoring reactions in natural product biosynthetic pathways. While most of these enzymes act on structurally complex pathway intermediates with high selectivity, they often exhibit narrow substrate scope, thus limiting their broader application. In the present study, we investigated the reactivity of the P450 MycCI from the mycinamicin biosynthetic pathway toward a variety of macrocyclic compounds and discovered that the enzyme exhibits appreciable activity on several 16-membered ring macrolactones independent of their glycosylation state. These results were corroborated by performing equilibrium substrate binding experiments, steady-state kinetics studies, and X-ray crystallographic analysis of MycCI bound to its native substrate mycinamicin VIII. We also characterized TylHI, a homologous P450 from the tylosin pathway, and showed that its substrate scope is severely restricted compared to MycCI. Thus, the ability of the latter to hydroxylate both macrocyclic aglycones and macrolides sets it apart from related biosynthetic P450s and highlights its potential for developing novel P450 biocatalysts with broad substrate scope and high regioselectivity.

First Total Synthesis of Mycinamicin IV and VII. Succesful Application of New Glycosidation Reaction

Matsumoto, Takahashi,Maeta, Hideki,Suzuki, Keisuke,Tsuchihashi, Gen-ichi

, p. 3575 - 3578 (2007/10/02)

First total synthesis of mycinamicin IV via mycinamicin VII is described.New glycosidation reaction using Cp2MCl2-AgClO4 (M=Zr, Hf) was effectively applied to the selective introduction of β-D-mycinosyl and β-D-desosaminyl linkages.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 77704-58-6